Age: 81.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Computerised tomogram, Dizziness, Pollakiuria, Post-acute COVID-19 syndrome
Clinical narrative: excessive urination 40 to 50 ounces usually at night; PTV Positional Vertigo; Long COVID; sleep disturbances; lightheaded; exposed to COVID and became COVID positive; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (exposed to COVID and became COVID positive), POLLAKIURIA (excessive urination 40 to 50 ounces usually at night), VERTIGO POSITIONAL (PTV Positional Vertigo), POST-ACUTE COVID-19 SYNDROME (Long COVID) and SLEEP DISORDER (sleep disturbances) in an 81-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 060F22A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: Flu shot in August 2022. Past adverse reactions to the above products included No adverse event with Flu shot. Concurrent medical conditions included Prostate cancer stage IV (using Lupron Injection every 6 months and Casodex twice daily.) since 2005, Blood pressure high (taking Metoprolol , Lisinopril, Norvasc, and Eliquis.) since 2010, High cholesterol (taking Simvastatin.) since 2010 and Esophageal reflux (taking Famotidine.) since 2010. Concomitant products included METOPROLOL, LISINOPRIL, AMLODIPINE BESILATE (NORVASC) and APIXABAN (ELIQUIS) for Blood pressure high, FAMOTIDINE for Esophageal reflux, SIMVASTATIN (SIMVASTATINE) for High cholesterol, LEUPRORELIN ACETATE (LUPRON) and BICALUTAMIDE (CASODEX) for Prostate cancer stage IV.    On 26-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 04-Nov-2022,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced COVID-19 (exposed to COVID and became COVID positive). On an unknown date, the patient experienced POLLAKIURIA (excessive urination 40 to 50 ounces usually at night), VERTIGO POSITIONAL (PTV Positional Vertigo), POST-ACUTE COVID-19 SYNDROME (Long COVID), SLEEP DISORDER (sleep disturbances) and DIZZINESS (lightheaded). The patient was treated with MOLNUPIRAVIR (LAGEVRIO) at a dose of 200 milligram. At the time of the report, COVID-19 (exposed to COVID and became COVID positive), POLLAKIURIA (excessive urination 40 to 50 ounces usually at night), VERTIGO POSITIONAL (PTV Positional Vertigo), POST-ACUTE COVID-19 SYNDROME (Long COVID), SLEEP DISORDER (sleep disturbances) and DIZZINESS (lightheaded) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Computerised tomogram: okay.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Reportedly, patient's wife reported that patient received 5 Moderna COVID-19 vaccine doses and had side effects. On 25-Feb-2021, patient received dose 1 with batch no. 002A21A, on 25-Mar-2021, patient received dose 2 with batch no. 006B21A, on 25-Oct-2021, patient received dose 3 (first booster)1 with batch no. 939906 and on 04-Apr-2022, patient received dose 4 (Second booster) with batch no. 033E21-2A.  After receiving 5th dose, patient was so lightheaded that he had to visit the Emergency room. He had excessive urination 40 to 50 ounces usually at night. The only reason they noticed the excess urination was because he had been using Urinal since prostate removal, many years ago. On 02-Nov-2022 her husband was exposed to COVID Virus at church, and he became COVID positive on 04-Nov-2022, he had light COVID symptoms, fever, chills and body ache. The symptoms were like a Flu.  The doctor gave Lagevrio 200 mg. On the 4th day taking Lagevrio 200 mg he was vomiting and he was Dizzy so they took him to the emergency room on 13-Nov-2022. He was in the Emergency room for 12 hours and was released on 14-Nov-2022. He was diagnosed with PTV Positional Vertigo. He had been using Meclizine over the counter for PTV. She stated they did not know if this was a drug interaction or it was related to the vaccine or a combination. He had long COVID, he still had fatigue, light headedness, and sleep disturbances.  No other treatment information was provided.